Innovation Spotlight San Francisco - Proventa International | Management Consultancy
  • +44 (0)20 70961222

 In Associated with:

 

INNOVATION SPOTLIGHT

 

Navigating the perceived daunting aspects with gaining data from first-in-human studies, through to Proof-of-Concept and dose ranging studies should never be seen as complex or time consuming. Logical approaches to optimize early phase clinical activities ensure the correct decisions can be critically made before future registration studies. The application of innovative strategies has proven that early phase clinical trials can be executed on time and within budget.

A specialist panel of early phase industry professionals has been assembled for one day round table discussions. Sharing their experiences with actual real case studies, from a range of different perspectives such as medical, regulatory, clinical, sponsor, and patients will be of major benefit to help develop your Early Phase strategy to Proof-of-Concept.

Benefits of Basket/Umbrella/Integrated Protocols over classical approaches

Understanding that Early Phase Trials are not small scale Phase 3 trials

How to implement adaptive study designs to successfully accelerate early phase trials

Transitioning a candidate from laboratory to humans

Extremely more effective Cohort Management by using a smaller number of sites

Future Early Phase Clinical Trial Concepts

 
 
 

DATE

June 20 2019

8:30AM - 5:45PM

LOCATION

InterContinental San Francisco

FEATURED SESSION

Advancing Optimization in Early Clinical Development

 

Advancing Optimization in Early Clinical Development

In association with:

 

In today’s fast-changing world, to stay competitive means to be innovative and open to embrace new approaches. Industry is facing time-pressing competition when fast movement through exploratory clinical phase is posing great challenges. Early go/no- go decisions have become critical. This is in contrast to dropping efficiency of clinical operations, constantly increasing complexity of study protocols and skyrocketing costs.

 
 
 

 

 

 

SUBSCRIBE TO OUR NEWSLETTER

Subscribe to our newsletter to receive latest updates of events & articles